prod:prod_dcx-login
Xpert® Xpress Flu/RSV
Accurate and reliable detection of Flu A, Flu B or RSV in as soon as 20 minutes*
Sign in or create a MyCepheid account to add items to cart
Test pack size(s)
10 Tests
XPRSFLU/RSV-10
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Collection devices
Copan 305CN (Nasopharyngeal Swab) (Pack of 50)
305C
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Copan 346N (Nasal Swab) (Pack of 50)
346C
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Nasopharyngeal Collection Kit (Pack of 100)
SWAB/B-100
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Nasal Collection Kit (Pack of 100)
SWAB/F-100
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Total
{{currency}}
0
Error adding items to cart. If this error persists, please contact Digital Support
The Need
- In patients of all ages, influenza and RSV often present with similar clinical symptoms, making it difficult to differentiate between the two infections1
- Sensitivities of Rapid EIA Flu tests range from 50-70%2
- Sensitivities of Rapid Antigen RSV tests average 29% in adults3
- Both Rapid EIA and Antigen manufacturers suggest confirming negative results with RT-PCR or culture2
- Rapid RSV tests may have age limitations4
(1) Falsey AR, Walsh EE. Respiratory Syncytial Virus Infection in Adults. Clin Microbiol Rev. 2000 Jul; 13.
(2) CDC. Guidance for Clinicians on the Use of Rapid Influenza Diagnostic Tests. Accessed Sep 2016. http://www.cdc.gov/flu/professionals/diagnosis/clinician_guidance_ridt.htm
(3) Chartrand C, et al. Diagnostic Accuracy of Rapid Antigen Detection Tests for Respiratory Syncytial Virus Infection: Systematic Review and Meta-analysis. J Clin Microbiol. 2015 Dec;53(12):3738-49.
(4) BD Veritor™System —For Rapid Detection of Flu A+B. Package Insert. DB. Dublin, Ireland. 2014.
(2) CDC. Guidance for Clinicians on the Use of Rapid Influenza Diagnostic Tests. Accessed Sep 2016. http://www.cdc.gov/flu/professionals/diagnosis/clinician_guidance_ridt.htm
(3) Chartrand C, et al. Diagnostic Accuracy of Rapid Antigen Detection Tests for Respiratory Syncytial Virus Infection: Systematic Review and Meta-analysis. J Clin Microbiol. 2015 Dec;53(12):3738-49.
(4) BD Veritor™System —For Rapid Detection of Flu A+B. Package Insert. DB. Dublin, Ireland. 2014.
The Solution
- Accurate and reliable detection of Flu A, Flu B and RSV in as soon as 20 minutes*
- Enables healthcare providers to quickly deliver targeted therapies
- Steamlines laboratory operations
- Improves patient satisfaction
* For positive Flu only or RSV only. Reporting negatives and combined reporting in 30 minutes.
The Impact
Single-test confidence will accelerate your laboratory's workflow with on-demand, random-access flexibility. Combine performance with the capability to run other Xpert® tests (including GBS, MRSA, C. difficile, CT/NG, and MTB/RIF) on Cepheid's GeneXpert® System to achieve proven productivity increases in overall laboratory service.5-9
Be Proactive
Be Proactive
- Achieve rapid results and improve patient management
- Early assay termination option: deliver positive results in as soon as 20 minutes* and negative results in 30 minutes
- Quickly deliver targeted therapies and increase peace of mind for patients
* For positive Flu only or RSV only. Reporting negatives and combined reporting in 30 minutes.
(5) Morgan MG. The Perfect Storm. Cepheid Impact. 2012 Jun;2:4-7.
(6) Parada JP. Increase Revenue and Improve Patient Safety. Cepheid Impact. 2012 Jun;2:8-11.
(7) El Helali N. Less Uncertainty - Better Safety - More Healthy Newborns. Cepheid Impact. 2012 Jul;3:4-7.
(8) Haynes L. The C. difficile Challenge. Cepheid Impact. 2012 Jul;3:10-15.
(9) Parada JP. Improving Patient Safety. Cepheid Impact. 2012 Oct;4:8-11.
(5) Morgan MG. The Perfect Storm. Cepheid Impact. 2012 Jun;2:4-7.
(6) Parada JP. Increase Revenue and Improve Patient Safety. Cepheid Impact. 2012 Jun;2:8-11.
(7) El Helali N. Less Uncertainty - Better Safety - More Healthy Newborns. Cepheid Impact. 2012 Jul;3:4-7.
(8) Haynes L. The C. difficile Challenge. Cepheid Impact. 2012 Jul;3:10-15.
(9) Parada JP. Improving Patient Safety. Cepheid Impact. 2012 Oct;4:8-11.
Related Products
Xpert CT/NG
90-minute detection and differentiation of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG)
Xpert Ebola
Accurate and Reliable Detection of Ebola Zaire Virus
Xpert Xpress Strep A
Delivers accurate and timely results that optimizes fast treatment decisions
Xpert MTB/RIF Ultra
Enhanced performance in detecting drug-sensitive and -resistant Tuberculosis in less than 80 minutes